Certara Inc

NASDAQ:CERT  
35.02
-0.43 (-1.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.40B
Current PEN/A
Forward PE 159.18
2yr Forward PE 109.44
See more stats
Estimates Current Quarter
Revenue$72.41 Million
Adjusted EPS$0.06
See more estimates
10-Day MA$34.85
50-Day MA$29.69
200-Day MAN/A
See more pivots

Certara Inc Stock, NASDAQ:CERT

100 Overlook Center, Suite 101, Princeton, New Jersey 08540
United States of America
Phone: +1.609.716.7900
Number of Employees: 300

Description

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.